PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer
出版年份 2022 全文链接
标题
PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer
作者
关键词
-
出版物
OncoImmunology
Volume 11, Issue 1, Pages -
出版商
Informa UK Limited
发表日期
2022-06-25
DOI
10.1080/2162402x.2022.2093518
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunogenic cell stress and death
- (2022) Guido Kroemer et al. NATURE IMMUNOLOGY
- Characteristics of the Immune Cell Infiltration Landscape in Gastric Cancer to Assistant Immunotherapy
- (2022) Chenlu Li et al. Frontiers in Genetics
- Immune Infiltration in Gastric Cancer Microenvironment and Its Clinical Significance
- (2022) An Zhi Zhang et al. Frontiers in Cell and Developmental Biology
- Oxaliplatin- versus cisplatin-based regimens for elderly individuals with advanced gastric cancer: a retrospective cohort study
- (2022) Takashi Chinen et al. BMC CANCER
- Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis
- (2022) Xiaofang Xing et al. Journal for ImmunoTherapy of Cancer
- Local anesthetics elicit immune-dependent anticancer effects
- (2022) Lucillia Bezu et al. Journal for ImmunoTherapy of Cancer
- Intratumoral heterogeneity in cancer progression and response to immunotherapy
- (2021) Ilio Vitale et al. NATURE MEDICINE
- ATP and cancer immunosurveillance
- (2021) Oliver Kepp et al. EMBO JOURNAL
- First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
- (2021) Yelena Y Janjigian et al. LANCET
- Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects
- (2021) Adriana Petrazzuolo et al. Cell Death & Disease
- Oxaliplatin facilitates tumor-infiltration of T cells and natural-killer cells for enhanced tumor immunotherapy in lung cancer model
- (2021) Min Xin et al. ANTI-CANCER DRUGS
- A novel oral metronomic chemotherapy provokes tumor specific immunity resulting in colon cancer eradication in combination with anti-PD-1 therapy
- (2021) Ruby Maharjan et al. BIOMATERIALS
- Oncolytic adenoviruses synergistically enhance anti-PD-L1 and anti-CTLA-4 immunotherapy by modulating the tumour microenvironment in a 4T1 orthotopic mouse model
- (2021) Huan Zhang et al. CANCER GENE THERAPY
- The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
- (2021) Yelena Y. Janjigian et al. NATURE
- Transdermal cold atmospheric plasma-mediated immune checkpoint blockade therapy
- (2020) Guojun Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
- (2020) Isaure Vanmeerbeek et al. OncoImmunology
- PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models
- (2020) Takahiro Yamazaki et al. OncoImmunology
- Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress
- (2020) Juliette Humeau et al. EMBO Molecular Medicine
- Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
- (2020) Lorenzo Galluzzi et al. Journal for ImmunoTherapy of Cancer
- Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy
- (2020) Takahiro Yamazaki et al. NATURE IMMUNOLOGY
- Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
- (2020) Lorenzo Galluzzi et al. Nature Reviews Clinical Oncology
- A decade of immune-checkpoint inhibitors in cancer therapy
- (2020) Caroline Robert Nature Communications
- Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy
- (2020) Hanzhang Zhu et al. CELLULAR ONCOLOGY
- Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
- (2020) Kohei Shitara et al. JAMA Oncology
- Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade
- (2020) Shivani Srivastava et al. CANCER CELL
- Anti-PD-1 antibody HX008 combined with oxaliplatin plus capecitabine for advanced gastric or esophagogastric junction cancer: a multicenter, single-arm, open-label, phase Ib trial
- (2020) Jianming Xu et al. OncoImmunology
- PD-1 Signaling Promotes Tumor-Infiltrating Myeloid-Derived Suppressor Cells and Gastric Tumorigenesis in Mice
- (2020) Woosook Kim et al. GASTROENTEROLOGY
- Non‐Thermal Plasma as a Unique Delivery System of Short‐Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells
- (2019) Abraham Lin et al. Advanced Science
- Oxaliplatin Treatment Alters Systemic Immune Responses
- (2019) Vanesa Stojanovska et al. Biomed Research International
- Tumor lysis with LTX-401 creates anticancer immunity
- (2019) Wei Xie et al. OncoImmunology
- Crizotinib-induced immunogenic cell death in non-small cell lung cancer
- (2019) Peng Liu et al. Nature Communications
- Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity
- (2019) Wei Xie et al. OncoImmunology
- A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice
- (2019) Sarah Lévesque et al. OncoImmunology
- Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages
- (2019) Emeric Limagne et al. Cancer Immunology Research
- Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma
- (2018) Stefania Orecchioni et al. BRITISH JOURNAL OF CANCER
- Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer
- (2018) Erta Kalanxhi et al. BRITISH JOURNAL OF CANCER
- Dinaciclib induces immunogenic cell death and enhances anti-PD1–mediated tumor suppression
- (2018) Dewan Md Sakib Hossain et al. JOURNAL OF CLINICAL INVESTIGATION
- Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
- (2018) Wantong Song et al. Nature Communications
- The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent
- (2018) Chloé Grasselly et al. Frontiers in Immunology
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- Comparative effectiveness and safety between oxaliplatin-based and cisplatin-based therapy in advanced gastric cancer: A meta-analysis of randomized controlled trials
- (2016) Jun Huang et al. Oncotarget
- Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer
- (2014) Y. Yamada et al. ANNALS OF ONCOLOGY
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- Crosstalk between ER stress and immunogenic cell death
- (2013) Oliver Kepp et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis
- (2011) Francesco Montagnani et al. Gastric Cancer
- Immunogenic death of colon cancer cells treated with oxaliplatin
- (2009) A Tesniere et al. ONCOGENE
- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
- (2008) David Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started